Labetalol Hydrochloride
NDC 10135-713, Labetalol, tablet, film coated, from Marlex Pharmaceuticals Inc.
- Product NDC
- 10135-713
- Status
- Listed
- Labeler
- Marlex Pharmaceuticals Inc
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075215
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10135-713 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LABETALOL300 mg/1
Pharmacologic classes
Adrenergic beta-Antagonists [MoA]; beta-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10135-713-01 | 10135071301 | 100 TABLET, FILM COATED in 1 BOTTLE (10135-713-01) |
| 10135-713-05 | 10135071305 | 500 TABLET, FILM COATED in 1 BOTTLE (10135-713-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/28c91727-e5a8-48b3-a4df-d7bec8feda40
Use it
Look up 10135-713 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10135-713 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10135-713. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.